BioVoice News December 2016-January 2017 Issue 8 Volume 1 - Page 42

news bytes

Pharma Major Lupin Limited ( Lupin ) and Eli Lilly and Company ( India ) on December 01 , 2016 announced an expansion of their partnership in India with the launch of Eglucent ®, a new brand of Lilly ’ s rapid-acting insulin analog Lispro .
According to the agreement , Lupin will market and sell Eglucent ® through its own specialty field force while Lilly will be responsible for manufacturing and import . Lilly will continue to sell Lispro under the brand name Humalog ® through its existing channels . Lupin had earlier collaborated with Lilly ( July , 2011 ) to promote and distribute Lilly ’ s Huminsulin range of products in India and Nepal .
Eglucent ® is indicated for the treatment of patients with diabetes mellitus . It is an injectable medication designed to improve blood sugar control in patients with type 1 and 2 diabetes . Eglucent ® will be available in the Indian market in both , the cartridge and disposable pen form . Eglucent ® is a prescription drug that should be taken only when prescribed by a registered physician . It is intended as an adjunct to diet and exercise to improve the glycemic control .
“ We have been very pleased with our partnership with Lupin and are happy to see it grow with the launch of Eglucent ®. The intent of this launch , which is the first for Lilly in the entire Emerging Markets region , is to increase the reach of analog insulin Lispro ® to more patients and healthcare professionals . We believe this is a big step in our journey to help fight the rising disease burden in India .” said Edgard Olaizola , Managing Director , Lilly India .
Strides Shasun Limited has announced the signing of definitive agreements to acquire the entire shareholding in Perrigo API India Private Limited ( Perrigo API India ) for INR 1000 Million . The transaction is subject to customary closing conditions and expected to be closed by December 31 , 2016 .
The Company already has a portfolio of integrated products under development and with the R & D teams for formulations and API working on a joint development platform , the Company is confident of reaching its stated filling run rate of 20-25 molecules which will largely comprise of integrated molecules .
Perrigo API India ’ s facility brings into the fold a US FDA approved API facility located at Ambernath , Maharashtra , to be used for captive consumption and will augment the Company ’ s resources to handle high velocity of new product development and commercial launches in the formulations portfolio . The facility with a potential capacity of 600 tons per year had zero 483s during its last US FDA inspection .
Commenting on the development , Shashank Sinha , Group CEO of Strides Shasun stated “ With this acquisition , we bring into
our fold a manufacturing facility designed to handle multipurpose small batch productions and accelerates our time to market . This augurs well for the Strides ’ stated strategy of building a backward integrated portfolio of niche and small volume products for the regulated markets .”
Biocon ’ s Chairperson and Managing Director Kiran Mazumdar- Shaw is enabling the showcase of a special exhibition of Science Gallery Bengaluru , ‘ Entanglement : A Dance between Art & Science ’ at the Serendipity Arts Festival in Goa this December . Conceptualized and produced by the Centre for Experimental Media and Arts ( CEMA ) at Srishti Institute of Art Design and Technology along with Science Gallery Dublin , ‘ Entanglement ’ will comprise a series of spectacles , experiments and projects on the fleeting boundaries of art-science-technology-culture- and philosophy .
This is the first edition of the Serendipity Arts Festival , a multidisciplinary arts event set over a period of eight days from December 16th to 23rd in Panaji , Goa . The festival will be curated by a panel of experts spanning all the major disciplines including the performing arts , visual arts , and culinary arts .
The ‘ Entanglement ’ exemplifies the connect between art and science and is an initiative by Science Gallery , Bengaluru , a partner of Science Gallery , Dublin under the auspices of Science Gallery International . The exhibition is jointly funded by Biocon Foundation , Biocon ’ s CSR Wing and the Department of IT , BT & Science and Technology , Government of Karnataka .
‘ Entanglement ’ will illustrate ones interaction and understanding of the natural and physical world . Through form , experience , and interaction , a collective of international and Indian artists , scientists , coders , and hackers will engage the public through projects on Environment , Gaming , Artificial Intelligence and Interactivity , and Physical Computing and Data Quantification .
Commenting on her association with the ‘ Entanglement ’, Dr Kiran Mazumdar-Shaw said , “ Through this unique Science Gallery Bengaluru showcase , I want to project the mélange of the art and the science . While these two disciplines are seemingly distinct , they together embody significant creative expression . Serendipity Arts Festival is the ideal platform to showcase ‘ Entanglement : Dance between Art & Science ’ since this festival aims to break the notion of art as an isolated silo and creates space for interdisciplinary exploration of art across disciplines .”
Stem cell research is a very fast growing field . The scientific community has witnessed major development in the field from autologous to allogeneic mesenchymal to embryonic and now induced pluripotent stem cells . ICMR has been regularly receiving claims on possible therapeutic solutions for varied disease conditions using stem cell .
Taking into consideration this situation and to understand position of India in global scenario , the Director General , ICMR invites ‘ Letter of Claim ’ on therapeutic use of stem cells from all
BioVoiceNews | December 2016 - January 2017